BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antitumor activities of some new N1-(flavon-6-yl)amidrazone derivatives. 2014

Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Faculty of Science, Chemistry Department, The University of Jordan, Amman, Jordan.

A new series of N1-(flavon-6-yl)amidrazones were synthesized by reacting the hydrazonoyl chloride derived from 6-aminoflavone with the appropriate sec-cyclic amines. The antitumor activities of these compounds were evaluated on breast cancer (MCF-7) and leukemic (K562) cell lines. Among the compounds tested, the N-morpholine derivative was the most active against the MCF-7 and K562 cell lines, with IC50 values of 5.18 and 2.89 μM, respectively. Our docking studies showed that the N-morpholino derivative fits and blocks the oncogenic tyrosine kinases bcr/abl and epidermal growth factor receptor (EGFR) in a similar fashion to that of the potent anticancer agent imatinib.

UI MeSH Term Description Entries
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068877 Imatinib Mesylate A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide,CGP 57148,CGP-57148,CGP57148B,Gleevec,Glivec,Imatinib,Imatinib Methanesulfonate,ST 1571,ST1571,STI 571,STI-571,STI571,CGP57148,Mesylate, Imatinib,Methanesulfonate, Imatinib
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001549 Benzamides BENZOIC ACID amides.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Synthesis and biological activity assays of some new N1-(flavon-7-yl)amidrazone derivatives and related congeners.
August 2012, European journal of medicinal chemistry,
Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Synthesis and antifungal activity of some amidrazone derivatives.
September 1989, Farmaco (Societa chimica italiana : 1989),
Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Synthesis and antihypertensive activity of some aminoguanidine and amidrazone derivatives.
October 1988, Archiv der Pharmazie,
Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Synthesis, and antitumor activity of some N1-(coumarin-7-yl) amidrazones and related congeners.
May 2011, Molecules (Basel, Switzerland),
Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Synthesis and antitumor activity of some new xanthotoxin derivatives.
July 2009, European journal of medicinal chemistry,
Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Synthesis of some new carbonitriles and pyrazole coumarin derivatives with potent antitumor and antimicrobial activities.
January 2014, Acta poloniae pharmaceutica,
Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Synthesis of 6-aziridinylbenzimidazole derivatives and their in vitro antitumor activities.
October 1998, Archives of pharmacal research,
Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Chemistry of phosphorus ylides. Part 33. Synthesis and antitumor activities of some new chromenone derivatives.
July 2011, Archiv der Pharmazie,
Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Design and synthesis of new tetrandrine derivatives and their antitumor activities.
October 2016, Journal of Asian natural products research,
Almeqdad Y Habashneh, and Mustafa M El-Abadelah, and Malek A Zihlif, and Amer Imraish, and Mutasem O Taha
Synthesis and antifungal activities of some new triazolylacetophenone derivatives.
May 1995, Arzneimittel-Forschung,
Copied contents to your clipboard!